Advisers to the Food and Drug Administration voted unanimously on Tuesday against the effectiveness of the key drug found in popular versions of Sudafed, Dayquil and other medications stocked on store shelves.

The FDA assembled its outside advisers to take another look at phenylephrine, which became the main drug in over-the-counter decongestants when medicines with an older ingredient — pseudoephedrine — were moved behind pharmacy counters. A 2006 law had forced the move because pseudoephedrine can be illegally processed into methamphetamine.

If the FDA follows through on the panel’s recommendations, Johnson & Johnson, Bayer and other drugmakers could be required to pull their oral medications containing phenylephrine from store shelves. That would likely force consumers to switch to the behind-the-counter pseudoephedrine products or to phenylephrine-based nasal sprays and drops.

  • flatbield@beehaw.org
    link
    fedilink
    English
    arrow-up
    3
    ·
    1 year ago

    Thanks. I did not see that in the article. The NYT article that someone else posted was more explicit. So I think you are correct. Hate to loose the nose spray version.

    • Domiku@beehaw.org
      link
      fedilink
      English
      arrow-up
      1
      ·
      1 year ago

      Yeah agreed. For oral meds, I always ask for the real pseudoephedrine behind the counter.

      • flatbield@beehaw.org
        link
        fedilink
        English
        arrow-up
        1
        ·
        1 year ago

        Yes, for oral pseudoephedrine works. Not sure why people just do not ask.

        The thing about pseudoephedrine, it does not agree with me at prescription strength (not sure I ever had a problem with over the counter version). One time years ago I took prescription strength, if affect my eye muscles, just couldn’t focus. Kind of freaked me out, so I avoid. Just me.

    • cobra89@beehaw.org
      link
      fedilink
      arrow-up
      1
      ·
      1 year ago

      From the article:

      But FDA reviewers said their latest assessment reflects new testing insights into how quickly phenylephrine is metabolized when taken by mouth, leaving only trace levels that reach nasal passages to relieve congestion. The drug appears more effective when applied directly to the nose, in sprays or drops, and those products are not under review.